By Authors

Publications - sorted by Authors

• Bampali K, Koniuszewski F, Silva L, Rehman S, Vogel F, Seidel T, Scholze P, Zirpel F, Garon A, Langer T, Willeit M, Ernst M (2022) Tricyclic antipsychotics and antidepressants can inhibit α5‐containing GABA _A receptors by two distinct mechanisms Br J Pharmacol, 0: 1-18

• Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Pezawas L, Praschak-Rieder N, Willeit M (2021) Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia Neuroimage Clin, 32: 102813
  | Weblink |

• Graf I, Willeit M, Kasper S, Praschak-Rieder (2021) The Impact of Genetic Polymorphisms on Neuroreceptor Binding: Results from PET and SPECT Neuroreceptor Imaging Studies. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Lammertsma AA (Hrsg.) PET and SPECT of Neurobiological Systems. . In: , Springer Nature Springer: 153-190
• Dajić I, Praschak-Rieder N, Lanzenberger R, Spindelegger C, Kasper S, Willeit M (2021) Neuroimaging in Seasons and Winter Depression. In: Rudi A.J.O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Iris E. Sommer, PET and SPECT in Psychiatry, Vol.2 Springer International Publishing: 245-259
  | Weblink |

• Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain Neuroimage, 223: 117270
  | Weblink |
• Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer B, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte H, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M (2020) On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study Transl Psychiat, 10 (2): 2
  | Weblink |

• Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S (2018) Rapid antidepressant effect of S-ketamine in schizophrenia Eur Neuropsychopharmacol, 28 (8): 980-982
  | Weblink |
• Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S (2018) DiGeorge syndrome Wien. Klin. Wochenschr., 130 (7-8): 283-287
  | Weblink |

• Weidenauer A, Sauerzopf U, Bartova L, Bauer M, Praschak-Rieder N, Kasper S, Willeit M (2018) Sensibilisierung auf Amphetamine: Bedeutung für die Schizophrenie- und Suchtforschung Journal für Neurologie, Neurochirurgie und Psychiatrie, 19 (2): 66-der 71
  | Weblink |
• Sauerzopf U, Weidenauer A Praschak-Rieder N, Kasper S Sitte H, Willeit M (2018) Reprogrammierte Zellen: Zukunft der psychiatrischen Forschung? Journal für Neurologie, Neurochirurgie und Psychiatrie, 19 (2): 60-63
  | Weblink |

• Akkaya-Kalayci T, Vyssoki B, Winkler D, Willeit M, Kapusta N, Dorffner G, Özlü-Erkilic Z (2017) The effect of seasonal changes and climatic factors on suicide attempts of young people BMC Psychiatry, 17 (1): 365
• Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N (2017) Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression J ECT, 33: e31-e32
  | Weblink |
• Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski J, Kasper S (2017) Administration of ketamine for unipolar and bipolar depression Int J Psychiatry Clin Pract, 21: 2-12
  | Weblink |
• Winkler D, Pjrek E, Spies M, Willeit M, Dorffner G, Lanzenberger R, Kasper S (2017) Has the existence of seasonal affective disorder been disproven? J Affect Disord, 208: 54-55
  | Weblink |
• Baldinger-Melich P, Weidenauer A, Linder C, Hienert M, Kasper S, Stamenkovic M, Willeit M (2017) Case Report: ECT in a patient with primary Parkinsonian syndrome and schizophrenia J ECT, 33 (1): e2-e3
  | Weblink |

• Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte H, Kasper S, Willeit M (2017) Making Sense of: Sensitization in Schizophrenia Int J Neuropsychopharmacol, 20 (1): 1-10
  | Weblink |

• Hienert M, Weidenauer A, Kraus C, Willeit M, Kasper S, Stamenkovic M (2016) Pregabalin in Tourette’s Syndrome: A Case Series Am J Psychiatry, 173 (12): 1242-1243
  | Weblink |
• Sauerzopf U, Sacco R, Novarino G, Niello M, Weidenauer A, Praschak-Rieder N, Sitte H, Willeit M (2016) Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence Eur J Neurosci, 45 (1): 45-57
• Hienert M, Weidenauer A, Kraus C, Willeit M, Kasper S, Stamenkovic M (2016) (2016) Pregabalin in Tourette syndrome Am J Psychiatry, 173: 1242-1243

• Willeit M, Vyssoki B, Kapusta N, Dorffner G, Kasper S, Praschak-Rieder N (2015) Sunshine Influences Suicide Rates Independent of Season Eur Psychiatry, 30: 28
• Bartova L, Vogl S, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M (2015) Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases Eur Neuropsychopharmacol, 25: 2183-2184

• Popovic A, Sauerzopf U, Kasper S, Willeit M (2015) Neuroimaging des Dopaminsystems bei Schizophrenie Jatros Neurologie & Psychiatrie ,

• Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova E, Kong E, Willeit M, Sotnikova T, Kudlacek O, Gether U, Freissmuth M, Pollak D, Gainetdinov R, Sitte H (2014) In vivo Amphetamine Action is Contingent on αCaMKII Neuropsychopharmacology, 39(11: :2681-2693
• Vyssoki B, Kapusta N, Praschak-Rieder N, Dorffner G, Willeit M (2014) Direct Effect of Sunshine on Suicide JAMA Psychiatry,
• Scharinger C, Rabl U, Kasess C, Meyer B, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H ,Brocke B, Moser E, Sitte H, Pezawas L (2014) Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity PLoS One, 9 (3): e92543

• Spindelegger C, Willeit M, Praschak-Rieder N, Lanzenberger R, Kasper S (2014) Neuroimaging in seasons and winter depression. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, den Boer JA (eds.), PET and SPECT in Psychiatry. Vol. 1. Berlin-Heidelberg-New York: Springer Verlag: pp. 209-222
• Willeit M, Kasper S, Praschak-Rieder N (2014) The impact of genetic polymorphisms on neuroreceptor imaging. In: den Boer JA, Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A (eds.), PET and SPECT of Neurobiological Systems. Vol. 3. Berlin-Heidelberg-New York: Springer Verlag: pp. 149-178

• Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W (2013) Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO Appl Radiat Isot, 82: 75-80

• Vyssoki B, Praschak-Rieder N, Sonneck G, Blüml V, Willeit M, Kasper S, Kapusta N (2012) Effects of sunshine on suicide rates Compr Psychiatry, 53 (5): 535-539
• Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien L, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R (2012) Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain World J Biol Psychiat, 13 (6): 413-422

• Bauer M, Praschak-Rieder N, Kasper S, Willeit M. (2012) Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence Curr Pharm Des, 12: 1568-1579

• Vyssoki B, Willeit M, Blüml V, Höfer P, Erfurth A, Psota G, Lesch O, Kapusta ND (2011) Inpatient treatment of major depression in Austria between 1989 and 2009: Impact of downsizing of psychiatric hospitals on admissions, suicide rates and outpatient psychiatric services J Affect Disord, 133 (1-2): 93-96
• Kapusta N, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K (2011) Lithium in drinking water and suicide mortality Br J Psychiatry, 198 (5): 346-350
• Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, Kasper S (2011) Bright-Light Therapy in the Treatment of Mood Disorders Neuropsychobiology, 64 (3): 152-162

• Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D (2009) Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. J Psychiatr Res, 43 (8): 792-797
• Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D (2009) Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: A pooled analysis J Psychiatr Res, 43 (8): 792-797

• Willeit M, Sitte H, Thierry N, Michalek K, Praschak-Rieder N, Zill P, Winkler D, Brannath W, Fischer M, Bondy B, Kasper S, Singer E (2008) Enhanced Serotonin Transporter Function during Depression in Seasonal Affective Disorder Neuropsychopharmacology, 33 (7): 1503-1513
• Pjrek E, Willeit M, Praschak-Rieder N, Konstantinidis A, Semlitsch H, Kasper S, Winkler D (2008) Treatment of Seasonal Affective Disorder with Duloxetine: An Open-Label Study Pharmacopsychiatry, 41 (3): 100-105

• Pjrek E, Winkler D, Stastny J, Praschak-Rieder N, Willeit M, Kasper S (2007) Escitalopram in Seasonal Affective Disorder: Results of an Open Trial Pharmacopsychiatry, 40 (1): 20-24
• Pjrek E, Winkler D, Praschak-Rieder N, Willeit M, Stastny J, Konstantinidis A, Kasper S (2007) Season of birth in siblings of patients with seasonal affective disorder Eur Arch Psychiatry Clin Neurosci, 257 (7): 378-382
• Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. (2007) Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder. Biol Psychiatry, 61(9): 1081-9

• Winkler D, Pjrek E, Konstantinidis A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S (2006) Anger attacks in seasonal affective disorder Int J Neuropsychopharmacol, 9 (02): 215
• Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S (2006) Agomelatine in the treatment of seasonal affective disorder Psychopharmycol, 190 (4): 575-579
• Pjrek E, Winkler D, Abramson D, Konstantinidis A, Stastny J, Willeit M, Praschak-Rieder N, Kasper S (2006) Serum lipid levels in seasonal affective disorder Eur Arch Psychiatry Clin Neurosci, 257 (4): 197-202

• Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Stastny J, Kasper S (2005) Actigraphy in Patients with Seasonal Affective Disorder and Healthy Control Subjects Treated with Light Therapy Biol Psychiatry, 58 (4): 331-336
• PRASCHAKRIEDER N, WILLEIT M, ZILL P, WINKLER D, THIERRY N, KONSTANTINIDIS A, MASELLIS M, BASILE V, BONDY B, ACKENHEIL M (2005) A Cys23–Ser23 substitution in the 5-HT receptor gene influences body weight regulation in females with seasonal affective disorder: An Austrian–Canadian collaborative study J Psychiatr Res, 39 (6): 561-567

• Thierry N, Willeit M, Praschak-Rieder N, Zill P, Hornik K, Neumeister A, Lenzinger E, Stastny J, Hilger E, Konstantinidis A, Aschauer H, Ackenheil M, Bondy B, Kasper S (2004) Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controls Eur Neuropsychopharmacol, 14 (1): 53-58
• Johansson C, Willeit M, Aron L, Smedh C, Ekholm J, Paunio T, Kieseppä T, Lichtermann D, Praschak-Rieder N, Neumeister A, Kasper S, Peltonen L, Adolfsson R, Partonen T, Schalling M (2004) Seasonal affective disorder and the G-protein β-3-subunit C825T polymorphism Biol Psychiatry, 55 (3): 317-319
• Pjrek E, Winkler D, Willeit M, Konstantinidis A, Thierry N, Kasper S (2004) Menstrual disturbances – a rare side-effect of bright-light therapy Int J Neuropsychopharmacol, 7 (2): 239-240

• Johansson C, Willeit M, Levitan R, Partonen T, Smedh C, Del Favero J, Bel Kacem S, Praschak-Rieder N, Neumeister A, Masellis M, Basile V, Zill P, Bondy B, Paunio T, Kasper S, Van Broeckhoven C (2003) The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality Psychol Med, 33 (5): 785-792
• Winkler D, Willeit M, Wolf R, Stamenkovic M, Tauscher J, Pjrek E, Konstantinidis A, Schindler S, Barnas C, Kasper S (2003) Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder Eur Neuropsychopharmacol, 13 (2): 129-134
• Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppä T, Lichtermann D, Praschak-Rieder N, Neumeister A, Nilsson L, Kasper S, Peltonen L, Adolfsson R, Schalling M, Partonen T (2003) Circadian Clock-Related Polymorphisms in Seasonal Affective Disorder and their Relevance to Diurnal Preference Neuropsychopharmacology, 28 (4): 734-739
• Leitner I, Praschak-Rieder N, Willeit M, Kasper S (2003) Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcome Int J Neuropsychopharmacol, 6 (2): 199-200
• Willeit M, Praschak-Rieder N, Zill P, Neumeister A, Ackenheil M, Kasper S, Bondy B (2003) C825T polymorphism in the G protein β3-Subunit gene is associated with seasonal affective disorder Biol Psychiatry, 54 (7): 682-686

• Willeit M, Praschak-Rieder N, Kasper S (2003) Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease] Wiener Klinische Wochenschrift, 15 (9): 281-290

• Winkler D, Willeit M, Praschak-Rieder N, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller HJ, Kasper S (2002) .Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. Eur Arch Psychiatry Clin Neurosci, : 252(2):54-62
• Winkler D, Praschak-Rieder N, Willeit M, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller HJ, Kasper S (2002) Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics. Nervenarzt, : 73(7):637-43
• Winkler D, Praschak-Rieder N, Willeit M, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller HJ, Kasper S (2002) Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics Nervenarzt, 73 (7): 637-643
• Praschak-Rieder N, Willeit M, Winkler D, Neumeister A, Hilger E, Zill P, Hornik K, Stastny J, Thierry N, Ackenheil M, Bondy B, Kasper S (2002) Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder Eur Neuropsychopharmacol, 12 (2): 129-134
• Winkler D, Willeit M, Praschak-Rieder N, Lucht M, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller H, Kasper S (2002) Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample Eur Arch Psychiatry Clin Neurosci, 252 (2): 54-62
• Neumeister A, Konstantinidis A, Stastny J, Schwarz M, Vitouch O, Willeit M, Praschak-Rieder N, Zach J, de Zwaan M, Bondy B, Ackenheil M, Kasper S (2002) Association Between Serotonin Transporter Gene Promoter Polymorphism(5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression Arch Gen Psychiatry, 59 (7): 613

• Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T (2002) Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology World J Biol Psychiatry, 3 (3): 133-146
• Hilger E, Praschak-Rieder N, Willeit M, Stastny J, Konstandinidis A, Neumeister A, Kasper S (2002) Pharmacotherapy of seasonal depression Nervenarzt, 73 (1): 22-9

• Stamenkovic M, Schindler S, Asenbaum S, Neumeister A, Willeit M, Willinger U, de Zwaan M, Riederer F, Aschauer H, Kasper S (2001) No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study Eur Neuropsychopharmacol, 11 (1): 69-74
• Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S (2001) Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med, : 31(8):1467-73
• Hilger E, Willeit M, Praschak-Rieder N, Stastny J, Neumeister A, Kasper S (2001) Reboxetine in seasonal affective disorder: an open trial. Eur Neuropsychopharmacol, : 11(1):1-5
• Kasper S, Quiner S, Barnas C, Fabisch H, Haushofer M, Sackel C, König P, Lingg A, Platz T, Rittmannsberger H, Stuppäck C, Willeit M, Zapotoczky HG (2001) Zotepine in the treatment of acute hospitalized schizophrenic episodes Int Clin Psychopharmacol, 16 (3): 163-8
• Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S (2001) Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls Psychol Med, 31 (8): 1467-73
• Hilger E, Willeit M, Praschak-Rieder N, Stastny J, Neumeister A, Kasper S (2001) Reboxetine in seasonal affective disorder: an open trial Eur Neuropsychopharmacol, 11 (1): 1-5
• Stamenkovic M, Schindler S, Asenbaum S, Neumeister A, Willeit M, Willinger U, de Zwaan M, Riederer F, Aschauer H, Kasper S (2001) No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study Eur Neuropsychopharmacol, 11 (1): 69-74
• Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brücke T, Kasper S (2001) [123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa Biol Psychiatry, 49 (4): 326-332
• Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Stastny J, Thierry N, Lenzinger E, Kasper S (2001) Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder J Affect Disord, 63 (1-3): 239-242
• Barnas C, Quiner S, Tauscher J, Hilger E, Willeit M, Küfferle B, Asenbaum S, Brücke T, Rao M, Kasper S (2001) In vivo 123I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients Psychopharmycol, 157 (3): 236-242
• Graf A, Wallner C, Schubert V, Willeit M, Wlk W, Fischer P, Kasper S, Neumeister A (2001) The effects of light therapy on mini-mental state examination scores in demented patients Biol Psychiatry, 50 (9): 725-727
• Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit M, Hilger E, Stastny J, Kasper S (2001) Monoaminergic function in the pathogenesis of seasonal affective disorder Int J Neuropsychopharmacol, 4 (04)

• Kasper S, Hilger E, Willeit M, Neumeister A, Praschak-Rieder N, Heßelmann B, Habeler A (2001) Drug Therapy. In: Partonen T, Magnusson A (eds.), Seasonal Affective Disorder: practice and research. New York: Oxford University Press: pp. 85-93
• Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit M, Hilger E, Stastny J, Kasper S (2001) Monoamines. In: Partonen T, Magnusson A (eds.), Seasonal Affective Disorders: practice and research. New York: Oxford University Press: pp. 201-217

• Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brücke T, Kasper S (2000) [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry, 47(6): 482-9
• Neumeister A, Pirker W, Willeit M, Praschak-Rieder N, Asenbaum S, Brücke T, Kasper S (2000) Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2β-carbomethoxy-3β- (4-iodophenyl)tropane and single photon emission computed tomography Biol Psychiatry, 47 (2): 158-160
• Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brücke T, Kasper S (2000) [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder Biol Psychiatry, 47 (6): 482-489

• Lenzinger E, Neumeister A, Praschak-Rieder N, Fuchs K, Gerhard E, Willeit M, Sieghart W, Kasper S, Hornik K, N. Aschauer H (1999) Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene? Psychiat Res, 85 (3): 241-246
• Neumeister A, Habeler A, Praschak-Rieder N, Willeit M, Kasper (1999) Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder? Int Clin Psychopharmacol, 14 (5): 313-5

• Heßelmann B, Habeler A, Praschak-Rieder N, Willeit M, Neumeister A, Kasper S (1999) Mirtazapine in seasonal affective disorder (SAD): A preliminary report Human Psychopharmacology Clinical and Experimental, 14: 59-62
• Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Kasper S (1999) Therapeutic sleep deprivation and phototherapy Wien Med Wochenschr, 149 (18): 520-4
• Neumeister A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S (1999) Monoamine depletion in non-pharmacological treatments for depression Adv Exp Med Biol, 467: 29-33

• Neumeister A, Stastny J, Praschak-Rieder N, Willeit M, Kasper S (1999) Light treatment in depression (SAD, s-SAD & non-SAD). In: Holick MF, Jung EG (eds.), Biologic Effects of Light 1998. Kluwer Academic Press: pp.409-416

• Kasper S, Neumeister A, Praschak-Rieder N, Heßelmann B, Willeit M, Habeler A (1998) Light therapy for other conditions than seasonal affective disorder (SAD). In: Hönigsmann H, Knobler R, Trautinger F, Jori G, Landmarks in Photobiology. Milano: OEMF spa: pp 520-524

• Praschak-Rieder N, Neumeister A, Hesselmann B, Willeit M, Barnas C, Kasper S (1997) Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases J Clin Psychiatry, 58 (9): 389-92